Scientific program
The following key issues of women's health at different stages of reproductive aging will be discussed at the conference:
- Molecular genetic, epigenetic, and immunological reasons of the reproductive system function impairment
- Determination of the women's reproductive system aging stages (STRAW+10 criteria) as the basis for the modern gynecological practice
- Genomic and non-genomic effects of endo- and exogenous sex hormones
- Cell technologies in gynecology
- Uterine bleeding in the context of modern drug therapy opportunities and latest recommendations
- Diagnosis of hyper- and androgen deficiency conditions and their correction
- Polycystic ovary syndrome: preservation of the reproductive function and health
- Impaired fat metabolism, metabolic syndrome and reproductive function
- Endocrinologic aspects of hormonal contraception
- Expansion of use of long-acting reversible contraceptives (LARC): global trend
- A "niche" of GnRH agonists/antagonists and sex hormones in gynecology
- Innovative therapies of uterine fibroids
- Endometriosis as a chronic inflammatory disease and principles of drug therapy
- The treatment of hyperplastic endometrial processes in view of recent recommendations
- Combined uterus pathology (uterine fibroids, adenomyosis, endometrial hyperplasia): focus on the uterus sparing
- Postmenopausal osteoporosis (therapeutic approaches)
- The role of hormones and metabolic disorders in the genesis of age-related osteoarthritis
- Genitourinary syndrome
- Gender differences in risk factors, course, and prevention of cardiovascular diseases: opportunities of MHT in view of recent evidence-based studies
- Menopause follow-up and MHT issues: consensus of the world's leading organizations
- MHT and gynecologic cancers
- Systemic MHT after preventive surgeries in BRCA gene mutation carriers
- The efficacy and safety of alternative therapy of menopausal disorders (SERM, TSEK, SSRI, SNRI, phytoestrogens, etc.)
- Various aspects of healthy aging and the role of a gynecologist